Jill M. Kolesar, PharmD | Authors

""PENINSULA EYE PHYSICIANS MEDICAL GROUP,INC.""

101 S SAN MATEO DR STE 310

Articles

Mitomycin as a Modulator of Irinotecan Anticancer Activity

August 01, 2002

Irinotecan and mitomycin (Mutamycin) possess significant single-agent activity against several tumor types, and mitomycin activates topoisomerase I, the cellular target of irinotecan. We conducted a phase I dose-escalation study of irinotecan and mitomycin in 37 evaluable patients with solid tumors. Antitumor responses included 2 complete responses, 5 partial responses, 10 minor responses, and a CA 19-9 tumor marker response.